(Q37813090)

23 August 2017

1 reference

title

Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology (English)

1 reference

23 August 2017

Bioactive Eicosanoids: Role of Prostaglandin F2α and F2-Isoprostanes in Inflammation and Oxidative Stress Related Pathology (English)

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

4 September 2024

0 references

Samar Basu

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21113821

4 September 2024

publication date

18 November 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s10059-010-0157-1.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

http://link.springer.com/article/10.1007/s10059-010-0157-1/fulltext.html

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

https://api.elsevier.com/content/article/PII:S1016847823111162?httpAccept=text/xml

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

https://api.elsevier.com/content/article/PII:S1016847823111162?httpAccept=text/plain

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

http://link.springer.com/content/pdf/10.1007/s10059-010-0157-1

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

4 September 2024

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

383-391

1 reference

The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0157-1

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0157-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0157-1

Presence of a 15-Ketoprostaglandin Delta13-Reductase in Porcine Cornea

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.3891/ACTA.CHEM.SCAND.46-0108

Passive cigarette smoking increases isoprostane formation.

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Maternal recognition of pregnancy--a review of the literature

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Metabolism of 8-iso-prostaglandin F2alpha

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Development of a continuous blood collection technique and a detailed study of prostaglandin F2 alpha release during luteolysis and early pregnancy in heifers

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Factors associated with oxidative stress in human populations

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid?

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost)

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Platelet activation in obese women: role of inflammation and oxidant stress

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidative stress markers in plasma and urine of prepubertal patients with type 1 diabetes mellitus

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Species differences in circulating prostaglandin metabolites. Relevance for the assay of prostaglandin release

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Profiles of prostaglandin metabolites in the human circulation. Identification of late-appearing, long-lived products.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Metabolism of prostaglandin E2 in the rat

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Atropine-antagonized miosis induced in the goat by intravenous infusions of prostaglandin E (PGE1 and PGE2).

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Induction of labour with prostaglandin F2a

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Prostaglandins in fertility control

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Termination of second trimester pregnancy with intramuscular administration of 16 phenoxy-ω-17,18,19,20 tetranor PGE2 methylsulfonylamide

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Intramuscular administration of 16 phenoxy omega 17,18,19,20 tetranor PGE2 methyl sulfonylamide for pre-operative cervical dilatation in first trimester nulliparae.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Luteolysis: a neuroendocrine-mediated event

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Insights into oxidative stress: the isoprostanes

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

The isoprostanes. Current knowledge and directions for future research

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Determination of urinary 8-epi-prostaglandin F(2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Production of eicosanoids by deendothelialized rabbit aorta: interaction between platelets and vascular wall in the synthesis of prostacyclin

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

The control of prostaglandin production by the endometrium in relation to luteolysis and menstruation

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Prostaglandins and thromboxanes

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Use of prostaglandin in cows with unobserved oestrus

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Production of prostanoids by rheumatic synovial cells in vitro: effects of anti-inflammatory drugs on arachidonic acid metabolism

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidant stress modulates murine allergic airway responses

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidative stress is associated with adiposity and insulin resistance in men.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Oxidative stress and antioxidant status in type 1 diabetes mellitus

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Allergen-induced airway disease is mouse strain dependent

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

Both cyclooxygenase- and cytokine-mediated inflammation are associated with carotid intima-media thickness

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

BAL fluid 8-isoprostane concentrations in eosinophilic bronchitis and asthma.

4 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10059-010-0157-1

4 September 2024

Identifiers

1 reference

23 August 2017

1 reference